product summary
Loading...
company name :
Tocris Bioscience
product type :
chemical
product name :
GW 583340 dihydrochloride
catalog :
2239/10
quantity :
10 mg (also 50 mg)
price :
179 USD
more info or order :
citations: 1
product information
brand :
Tocris, a Bio-Techne brand
catalog number base :
2239
SKU :
2239/10
product name :
GW 583340 dihydrochloride
description :
Potent dual EGFR/ErbB2 inhibitor; orally active
target :
EGF Receptor Inhibitors
unit size :
10 mg (also 50 mg)
category :
Small Molecules
purity :
97%
storage :
Desiccate at +4°C
observed molecular weight :
671.03
url print :
?utm_source=biocompare&utm_medium=referral&utm_campaign=product&utm_term=smallmolecules
details of functionality :
GW 583340 dihydrochloride is a potent dual EGFR/ErbB2 tyrosine kinase inhibitor (IC50 values are 0.01 and 0.014 u M respectively). Selectively inhibits growth of human tumor cells overexpressing EGFR and ErbB2 (IC50 values are 0.11 u M for inhibition of HN5, N87 and BT474 tumor cell lines vs. 30 u M for inhibition of non-tumor cell line HFF). Inhibits tumor growth in vivo by ~ 80% in a murine xenograft model following oral administration.
product keywords :
Potent dual EGFR ErbB2 inhibitors inhibits orally active Epidermal Growth Factors Receptors Her Receptor Tyrosine Kinases RTKs GW583340 dihydrochloride GlaxoSmithKline GSK EGFR 2239,
extended description :
Potent dual EGFR/ErbB2 inhibitor; orally active
chemical name text :
N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[2-[[[2-(methylsulfonyl)ethyl]amino]methyl]-4-thiazolyl]-4-quinazolinamine dihydrochloride
formula :
C28H25ClFN5O3S2.2HCl
formula text :
C28H25ClFN5O3S2.2HCl
cas num :
1173023-85-2
USD :
198
USD 2025 :
179 USD
product details :
Potent dual EGFR/ErbB2 inhibitor; orally active
more info or order :
company information

Tocris Bioscience
The Watkins Building
Atlantic Road
Avonmouth, Bristol
BS11 9QD
Atlantic Road
Avonmouth, Bristol
BS11 9QD
info@bio-techne.com
https://www.tocris.com800-343-7475
headquarters: UK
related products
browse more products
questions and comments